drugset
drugset / Trial / NCT05832697

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

NCT05832697 ↗

Phase 1 Completed 44 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to Evaluate and Compare Safety and Pharmacokinetic Characteristics after Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers.

Timeline

Start
2022-01-27
Primary completion
2023-01-30
Completion
2023-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ursodeoxycholic Acid Small molecule 100 mg Oral
Comparator Ursodeoxycholic Acid Small molecule 250 mg Oral

Indications

No indication recorded.